| Schedule of Presents the Outstanding Warrants |
| 3) | The following table presents the outstanding warrants, as of June 30, 2026 and their terms: | | Date of issuance | | Number of outstanding warrants(**) | | | Exercise price for one Ordinary share(**) | | | Expiration date | | February 16, 2023 | | | 204 | | | $ | 17,493 | | | November 29, 2027 | | February 16, 2023 | | | 19 | (*) | | NIS | 64,362 | | | November 29, 2027 | | June 15, 2023 | | | 237 | | | $ | 12,600 | | | June 12, 2028 | | January 25, 2024 | | | 847 | | | $ | 5,250 | | | January 25, 2029 | | May 14, 2025 | | | 2,198 | | | $ | 787.5 | | | May 14, 2030 | | July 28, 2025 | | | 15,110 | | | $ | 87.36 | | | July 7, 2030 | | September 30, 2025 | | | 45,627 | | | $ | 87.36 | | | September 30, 2030 | | December 4, 2025 | | | 24,573 | | | $ | 87.36 | | | December 4, 2030 | | December 30, 2025 | | | 11,447 | | | $ | 87.36 | | | December 30, 2030 | | February 12, 2026 | | | 11,447 | | | $ | 87.36 | | | February 11, 2031 | | March 10, 2026 | | | 11,447 | | | $ | 87.36 | | | March 9, 2031 | | April 27,2026 | | | 11,447 | | | $ | 87.36 | | | April 26, 2031 | | June 1, 2026 | | | 99,800 | | | $ | 87.36 | | | May 31, 2031 | | June 15, 2026 | | | 149,701 | | | $ | 87.36 | | | June 14, 2031 | | (*) | Classified as a warrants’ liability of $0. | | (**) | Number of outstanding warrants and exercise prices have been adjusted to give retroactive effect to the down round anti-dilution provision included in the terms of such warrants, as affected by new equity investments up to June 30, 2026 (see also note 9B). |
|
| Schedule of Share Option Awards Outstanding and the Related Weighted Average Exercise Price |
Information on the share option awards outstanding and the related weighted average exercise price as of and for the six months ended June 30, 2026, are presented in the table below: | Relating to options: | | Number of potential Ordinary Shares | | | Exercise price range* | | | Aggregate Intrinsic Value | | | Outstanding at beginning of the period | | | 6,718 | | | $ | 2.1-$259,440 | | | $ | 504,765 | | | Granted | | | - | | | | - | | | | - | | | Forfeited | | | - | | | | - | | | | - | | | Expired | | | - | | | | - | | | | - | | | Outstanding at end of the period | | | 6,718 | | | $ | 2.1-$259,440 | | | $ | 13,085 | | | Exercisable at end of the period | | | 1,981 | | | $ | 2.1-$259,440 | | | $ | 4,491 | | | * | Per 1 Ordinary Share with no par value. |
|
| Schedule of Stock-Based Awards Outstanding |
The following table summarizes information about stock-based awards outstanding and exercisable at June 30, 2026: | | | Outstanding | | | Exercisable | | | Exercise price range | | Number of potential Ordinary Shares | | | Weighted average remaining contractual life (years) | | | Number of potential Ordinary Shares | | | Weighted average remaining contractual life (years) | | | $2.1-$871.5 | | | 6,643 | | | | 4.3 | | | | 1,906 | | | | 4.3 | | | $42,000-$64,470 | | | 40 | | | | 5.7 | | | | 40 | | | | 5.7 | | | $105,000 | | | 6 | | | | 2.0 | | | | 6 | | | | 2.0 | | | $129,660;$194,550;$259,440 | | | 29 | | | | 5.7 | | | | 29 | | | | 5.7 | | | | | | 6,718 | | | | 4.3 | | | | 1,981 | | | | 4.4 | |
|
| Schedule of Fair Value of Option Grants |
The calculated fair value of options granted in the six months period ended June 30, 2025 was estimated using the Black-Scholes pricing model with the following assumptions (no options were granted in 2026): | Risk-free interest rate | | | 4.57 | % | | Expected option term (in years) | | | 5 | | | Expected price volatility | | | 120 | % | | Fair value of an ordinary share | | $ | 2,360.4 | | | Dividend yield | | | 0 | % |
|